ResNovas Therapeutics
PrivateLast Round
Grant
Apr 28, 2026
Total Funding Raised
$500,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
ResNovas Therapeutics is a drug discovery company developing targeted protein degradation therapies designed to enable treatment of disease at the molecular level.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ResNovas Therapeutics Comparables
Compare ResNovas Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neuvivo | 80% | |
| QurAlis | 76% | |
| Coya Therapeutics, Inc. | 74% | |
ResNovas Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 28, 2026 | ||||
| Pre Seed | Dec 31, 2025 | ||||
| Accelerator | Oct 9, 2025 | ||||
| Accelerator | Sep 30, 2025 | ||||
| Seed | Aug 15, 2024 |
ResNovas Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Pre Seed |
| StartX | Accelerator |
| Dalena Capital | Seed |
| Astellas Venture Management | Seed |
| Ono Venture Investment, Inc. | Pre Seed |
| Mission BioCapital | Pre Seed, Seed |
| TIAP | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2026
Received grant funding from AbbVie and MBC BioLabs.
- Dec 31, 2025
$500K raised from Ono Venture Investment, Connecticut Innovations, and others.
ResNovas Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ResNovas Therapeutics's valuation, stock price, and market status.